Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
February 01, 2024 at 03:00 am EST
Share
Dr. Lal PathLabs Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 5,389 million compared to INR 4,894 million a year ago. Revenue was INR 5,572 million compared to INR 4,999 million a year ago. Net income was INR 813 million compared to INR 528 million a year ago. Basic earnings per share from continuing operations was INR 9.77 compared to INR 6.37 a year ago. Diluted earnings per share from continuing operations was INR 9.76 compared to INR 6.35 a year ago.
For the nine months, sales was INR 16,812 million compared to INR 15,259 million a year ago. Revenue was INR 17,320 million compared to INR 15,534 million a year ago. Net income was INR 2,732 million compared to INR 1,822 million a year ago. Basic earnings per share from continuing operations was INR 32.88 compared to INR 22 a year ago. Diluted earnings per share from continuing operations was INR 32.81 compared to INR 21.92 a year ago.
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Companyâs subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
DR. LAL PATHLABS LIMITED 
